These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 19001815)

  • 41. C4d peritubular capillary staining in chronic allograft nephropathy and transplant glomerulopathy: an uncommon finding.
    Al Aly Z; Yalamanchili P; Cortese C; Salinas-Madrigal L; Bastani B
    Transpl Int; 2005 Jul; 18(7):800-5. PubMed ID: 15948858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. C4d-positive chronic rejection: a frequent entity with a poor outcome.
    David-Neto E; Prado E; Beutel A; Ventura CG; Siqueira SA; Hung J; Lemos FB; de Souza NA; Nahas WC; Ianhez LE; David DR
    Transplantation; 2007 Dec; 84(11):1391-8. PubMed ID: 18091514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of different staining techniques for c4d detection in renal allograft biopsies.
    Ludovico-Martins H; Silva C; Teodoro WR; Martini Filho D; Noronha IL
    Transplant Proc; 2009 Apr; 41(3):862-5. PubMed ID: 19376373
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Three-year outcome of isolated glomerulitis on 3-month protocol biopsies of donor HLA antibody negative patients.
    Buob D; Grimbert P; Glowacki F; Labalette M; Dufossé F; Nochy D; Copin MC; Boleslawski E; Noël C; Hazzan M
    Transpl Int; 2012 Jun; 25(6):663-70. PubMed ID: 22487459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Late kidney dysfunction in a kidney transplant recipient.
    Josephson MA
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):590-7. PubMed ID: 24370771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and pathological analysis of transplant glomerulopathy cases.
    Shimizu T; Tanabe T; Shirakawa H; Omoto K; Ishida H; Tanabe K
    Clin Transplant; 2012 Jul; 26 Suppl 24():37-42. PubMed ID: 22747474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rejection of the Renal Allograft in the Absence of Demonstrable Antibody and Complement.
    Zhao X; Huang G; Randhawa S; Zeng G; Lunz J; Randhawa P
    Transplantation; 2017 Feb; 101(2):395-401. PubMed ID: 26901079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Donor-specific antibodies, C4d and their relationship with the prognosis of transplant glomerulopathy.
    Lesage J; Noël R; Lapointe I; Côté I; Wagner E; Désy O; Caumartin Y; Agharazii M; Batal I; Houde I; De Serres SA
    Transplantation; 2015 Jan; 99(1):69-76. PubMed ID: 25073036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transplant rejection under the microscope.
    Crosson JT
    Transplant Proc; 2007 Apr; 39(3):662-6. PubMed ID: 17445568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of HLA-specific antibodies in kidney transplant rejection: published studies and local data.
    Worthington JE; Martin S; Barker AJ; McWilliam LJ; Dyer PA
    Clin Transpl; 2006; ():349-61. PubMed ID: 18365389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathological analysis of transplant glomerulopathy cases.
    Shimizu T; Ishida H; Shirakawa H; Omoto K; Tsunoyama K; Iida S; Tanabe K; Yamaguchi Y
    Clin Transplant; 2009 Aug; 23 Suppl 20():39-43. PubMed ID: 19594595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. C4d deposition is correlated with the level of antivimentin antibody in rat kidneys undergoing chronic allograft nephropathy.
    Yang L; Lu YP; Luo GH; Song J; Tu ZD; Li YP
    Transplant Proc; 2008 Oct; 40(8):2786-9. PubMed ID: 18929862
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotypes of antibody-mediated rejection in organ transplants.
    Mengel M; Husain S; Hidalgo L; Sis B
    Transpl Int; 2012 Jun; 25(6):611-22. PubMed ID: 22533649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Focal peritubular capillary C4d deposition in acute rejection.
    Magil AB; Tinckam KJ
    Nephrol Dial Transplant; 2006 May; 21(5):1382-8. PubMed ID: 16396975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts.
    Collins AB; Chicano SL; Cornell LD; Tolkoff-Rubin N; Goes NB; Saidman SL; Farrell ML; Cosimi AB; Colvin RB
    Transplant Proc; 2006 Dec; 38(10):3427-9. PubMed ID: 17175293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glomerular C3c deposition and intravascular macrophage accumulation in early humoral renal allograft rejection signifies a poor short-term outcome.
    Mölne J; Nyberg G; Blohmé I; Rydberg L; Breimer ME; Svalander CT
    APMIS; 2006 Oct; 114(10):700-11. PubMed ID: 17004973
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of peritubular capillaries in the development of chronic allograft nephropathy.
    Ishii Y; Sawada T; Kubota K; Fuchinoue S; Teraoka S; Shimizu A
    Transplant Proc; 2005 Mar; 37(2):981-3. PubMed ID: 15848597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Post-transplantation anti-HLA antibodies: which relevance?].
    Glotz D
    Nephrol Ther; 2008 Jun; 4 Suppl 1():S8-S12. PubMed ID: 18703400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current problems of chronic active antibody-mediated rejection.
    Takeda A; Horike K; Ohtsuka Y; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
    Clin Transplant; 2011 Jul; 25 Suppl 23():2-5. PubMed ID: 21623906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
    Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B
    Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.